当前位置: 易推广 > 生物试剂/抗体/细胞 > 生化试剂 > 其他 > 继圣(上海)医疗器械有限公司 > 产品展示 > Calcitonin多克隆抗体
Calcitonin多克隆抗体
企业档案
会员类型:会员
已获得易推广信誉 等级评定
41成长值
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:4年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:经销商 【已认证】
注册资金:人民币万 【已认证】
产品数:3388
参观次数:726456
详细内容
Calcitonin多克隆抗体
Polyclonal
7 mL BOND ready-to-use PA0406 P (Enzyme)
Antigen Background
Calcitonin (CT) is a 32 amino acid peptide synthesized by the parafollicular C
cells of the thyroid. It acts through its receptors to inhibit osteoclast mediated
bone resorption, decrease calcium resorption by the kidney and decrease
calcium absorption by the intestines. The action of calcitonin is therefore to
cause a reduction in serum calcium, an effect opposite to that of parathyroid
hormone. The calcitonin gene transcript also encodes the calcitonin generelated peptide (CGRP), which is thought to be a potent vasodilator. The tissue specificity of the transcript produced depends on alternative splicing of the
CT/CGRP gene transcript. In the parafollicular cells of the thyroid 95 percent
of the CT/CGRP is processed and translated to produce CT, however, in
neuronal cells 99 percent of the CT/CGRP RNA is translated into CGRP. The C
cells of the thyroid give rise to an endocrine tumor, medullary thyroid
carcinoma (MTC), which occurs in a sporadic (75 percent of cases) and
hereditary form (25 percent of cases). Familial MTC is associated with C cell
hyperplasia (CCH), whereas sporadic MTC is thought not to be. However, in
the general population CCH is present in 20-30 percent of thyroid glands,
either with normal histology, thyroiditis or follicular tumors.
Medullary carcinoma: immunohistochemical staining with BOND ready-to-use Calcitonin
(Polyclonal) using BOND Polymer Refine Detection.
Polyclonal
7 mL BOND ready-to-use PA0406 P (Enzyme)
Antigen Background
Calcitonin (CT) is a 32 amino acid peptide synthesized by the parafollicular C
cells of the thyroid. It acts through its receptors to inhibit osteoclast mediated
bone resorption, decrease calcium resorption by the kidney and decrease
calcium absorption by the intestines. The action of calcitonin is therefore to
cause a reduction in serum calcium, an effect opposite to that of parathyroid
hormone. The calcitonin gene transcript also encodes the calcitonin generelated peptide (CGRP), which is thought to be a potent vasodilator. The tissue specificity of the transcript produced depends on alternative splicing of the
CT/CGRP gene transcript. In the parafollicular cells of the thyroid 95 percent
of the CT/CGRP is processed and translated to produce CT, however, in
neuronal cells 99 percent of the CT/CGRP RNA is translated into CGRP. The C
cells of the thyroid give rise to an endocrine tumor, medullary thyroid
carcinoma (MTC), which occurs in a sporadic (75 percent of cases) and
hereditary form (25 percent of cases). Familial MTC is associated with C cell
hyperplasia (CCH), whereas sporadic MTC is thought not to be. However, in
the general population CCH is present in 20-30 percent of thyroid glands,
either with normal histology, thyroiditis or follicular tumors.
Medullary carcinoma: immunohistochemical staining with BOND ready-to-use Calcitonin
(Polyclonal) using BOND Polymer Refine Detection.
热门标签:多克隆 Polyclonal 徕卡抗体